PT Kalbe, Amarox launch Movfor COVID-19 antiviral drug
Primarily based on the outcomes of the Section 3 medical trial, Molnupiravir is efficient towards the ...
Read morePrimarily based on the outcomes of the Section 3 medical trial, Molnupiravir is efficient towards the ...
Read more Copyright © 2021 198 Indonesia News.
All Rights Reserved.
Copyright © 2021 198 Indonesia News.
All Rights Reserved.